¶óÆæÆ®¦¢Ä«Æä¦¢ºí·Î±×¦¢´õº¸±â
¾ÆÄ«µ¥¹Ì Ȩ ¸í»çƯ°­ ´ëÇבּ¸½Ç޹æ Á¶°æ½Ç¹« µ¿¿µ»ó°­ÀÇ Çѱ¹ÀÇ ÀüÅëÁ¤¿ø ÇÐȸº° ³í¹®
ÇÐȸº° ³í¹®

Çѱ¹°Ç¼³°ü¸®ÇÐȸ
Çѱ¹°ÇÃà½Ã°øÇÐȸ
Çѱ¹µµ·ÎÇÐȸ
Çѱ¹»ý¹°È¯°æÁ¶ÀýÇÐȸ
Çѱ¹»ýÅÂÇÐȸ
Çѱ¹¼öÀÚ¿øÇÐȸ
Çѱ¹½Ä¹°ÇÐȸ
Çѱ¹½Ç³»µðÀÚÀÎÇÐȸ
Çѱ¹ÀÚ¿ø½Ä¹°ÇÐȸ
Çѱ¹ÀܵðÇÐȸ
Çѱ¹Á¶°æÇÐȸ
Çѱ¹Áö¹Ý°øÇÐȸ
Çѱ¹ÇÏõȣ¼öÇÐȸ
Çѱ¹È¯°æ»ý¹°ÇÐȸ
Çѱ¹È¯°æ»ýÅÂÇÐȸ

Çѱ¹ÀÚ¿ø½Ä¹°ÇÐȸ / v.3, no.2, 1990³â, pp.129-138
õ¿¬¹° À¯·¡Ç׾Ϲ°Áú °Ë»öªÎª¿ªáªÎ«¹«¯«ê-«Ë«½«°¿¬±¸
( Current Progress in the Screening for Antitumor Drugs of National Origin )
ÄÚÀÌÄ¡; ;
 
ÃÊ ·Ï
Now, many anticancer drugs are applying in the clinical side, but there is no conclusive effect of such a chemotherapy. Development ofnovel clinical useful anticancer drugs would be dependenton the screen-ing system and its test sample sources. So, it is necessary to outlinesome background on the tumor systems which have been used for screen-ing. This paper describes mainely on National Cancer Institute (NCI)program for anticancer screening systems, because the large number ofcompounds have been screened at NCI prograB and their relationship ofassesment between experimental animals and clinical Patients has beendiscussing and the uniform screefing protocols for various tumorsystens. At the end of this paper, some literatures of antitunor substances from various higher Plants at our laboratory are showed.
 
Ű¿öµå
 
Çѱ¹ÀÚ¿ø½Ä¹°ÇÐȸÁö / v.3, no.2, 1990³â, pp.129-138
Çѱ¹ÀÚ¿ø½Ä¹°ÇÐȸ
ISSN : 1226-3591
UCI : G100:I100-KOI(KISTI1.1003/JNL.JAKO199011920277482)
¾ð¾î : Çѱ¹¾î
³í¹® Á¦°ø : KISTI Çѱ¹°úÇбâ¼úÁ¤º¸¿¬±¸¿ø
¸ñ·Ïº¸±â
ȸ»ç¼Ò°³ ±¤°í¾È³» ÀÌ¿ë¾à°ü °³ÀÎÁ¤º¸Ãë±Þ¹æÄ§ Ã¥ÀÓÀÇ ÇѰè¿Í ¹ýÀû°íÁö À̸ÞÀÏÁÖ¼Ò ¹«´Ü¼öÁý °ÅºÎ °í°´¼¾ÅÍ
   

ÇÏÀ§¹è³ÊÀ̵¿